| BSX | Wells Fargo | — | $50 → $48 | Target cut to $48 from $50 (+7.6% to spot) | — |
| ROL | Piper Sandler | — | $33 | Target set to $33 (+1.6% to spot) | — |
| FRVO | Johnson Rice | — | $35 | Target set to $35 (+114.1% to spot) | — |
| SKHY | Wolfe Research | — | $200 → $250 | Target raised to $250 from $200 (+31.4% to spot) | — |
| GE | Jefferies | — | $455 → $435 | Target cut to $435 from $455 (+35.3% to spot) | — |
| FSSL | Compass Point | — | $15.75 | Target set to $15.75 (+34.6% to spot) | — |
| ANAB | Leerink | — | $90 → $81 | Target cut to $81 from $90 (+59.9% to spot) | — |
| WFRD | UBS | — | $116 | Target set to $116 (+37% to spot) | — |
| AZO | Truist Securities | — | $3648 | Target set to $3648 (+31.2% to spot) | — |
| MTB | Truist | — | $268 → $250 | Target cut to $250 from $268 (+12.6% to spot) | — |
| RF | Truist | — | $34 → $31 | Target cut to $31 from $34 (+12.3% to spot) | — |
| KBH | Evercore ISI | — | $62 → $59 | Target cut to $59 from $62 (+22.2% to spot) | — |
| FSLY | DA Davidson | — | $21 → $23 | Target raised to $23 from $21 (-7.5% to spot) | AEI |
| VKTX | Truist | — | $83 → $87 | Target raised to $87 from $83 (+129.1% to spot) | HALO |
| NKE | Oppenheimer | — | $60 → $52 | Target cut to $52 from $60 (+44.8% to spot) | — |
| AMRZ | Deutsche Bank | — | $64 → $56 | Target cut to $56 from $64 (+46.8% to spot) | — |
| ACHC | Leerink | — | $30 → $33 | Target raised to $33 from $30 (+14.5% to spot) | — |
| CLDX | Leerink | — | $70 → $88 | Target raised to $88 from $70 (+182.2% to spot) | — |
| MELI | New Street | — | $2450 | Target set to $2450 (+35.3% to spot) | HALO · AW40 |
| QNRX | Lake Street | — | $20 | Target set to $20 (+172.5% to spot) | — |
| FITB | Truist | — | $64 → $63 | Target cut to $63 from $64 (+19.4% to spot) | — |
| HBAN | Truist | — | $20 → $19 | Target cut to $19 from $20 (+21.1% to spot) | — |
| KBH | RBC Capital | — | $53 → $50 | Target cut to $50 from $53 (+2.9% to spot) | — |
| NKTR | Wedbush | — | $80 → $50 | Target cut to $50 from $80 (-18% to spot) | — |
| AZO | BMO Capital | — | $4000 → $3500 | Target cut to $3500 from $4000 (+20.9% to spot) | — |
| STZ | UBS | — | $168 → $145 | Target cut to $145 from $168 (+23.3% to spot) | — |
| PATH | UBS | — | $19 → $15 | Target cut to $15 from $19 (+13.2% to spot) | Euro-AI · AW40 |
| PM | UBS | — | $182 → $192 | Target raised to $192 from $182 (+0.9% to spot) | — |
| AZO | Roth Capital | — | $4023 → $3850 | Target cut to $3850 from $4023 (+33% to spot) | — |
| THO | Roth Capital | — | $78 → $74 | Target cut to $74 from $78 (+0.3% to spot) | — |
| CGNX | Baird | — | $78 → $70 | Target cut to $70 from $78 (+18.7% to spot) | Rubin |
| AZO | Baird | — | $3600 → $3400 | Target cut to $3400 from $3600 (+17.5% to spot) | — |
| PATH | Truist Securities | — | $14 | Target set to $14 (+8.5% to spot) | Euro-AI · AW40 |
| MU | Wells Fargo | — | $1400 | Target set to $1400 (+27.7% to spot) | Rubin |
| AZO | TD Cowen | — | $3400 | Target set to $3400 (+17.5% to spot) | — |
| TLSI | H.C. Wainwright | — | $12 | Target set to $12 (+143.4% to spot) | — |
| VLO | Goldman Sachs | — | $365 → $457 | Target raised to $457 from $365 (+21.2% to spot) | — |
| CLDX | Morgan Stanley | — | $50 → $57 | Target raised to $57 from $50 (+70.1% to spot) | — |
| GD | Bernstein | — | $421 → $407 | Target cut to $407 from $421 (+18.5% to spot) | — |
| NOC | Bernstein | — | $653 → $620 | Target cut to $620 from $653 (+21.6% to spot) | — |
| TTI | Stifel | — | $13 → $12 | Target cut to $12 from $13 (+99.3% to spot) | — |
| KBH | BofA Securities | — | $54 | Target set to $54 (+11.1% to spot) | — |
| AZO | Mizuho | — | $3000 | Target set to $3000 (+3.6% to spot) | — |
| KLC | Morgan Stanley | — | $2.5 → $2 | Target cut to $2 from $2.5 (-13.8% to spot) | — |
| BFAM | Morgan Stanley | — | $68 → $66 | Target cut to $66 from $68 (+1.6% to spot) | — |
| CMPX | Guggenheim | — | $4 | Target set to $4 (+222.6% to spot) | — |
| AZO | Guggenheim | — | $4000 → $3750 | Target cut to $3750 from $4000 (+29.5% to spot) | — |
| DPZ | Guggenheim | — | $440 → $325 | Target cut to $325 from $440 (+9.4% to spot) | — |
| THO | Baird | — | $90 → $80 | Target cut to $80 from $90 (+8.4% to spot) | — |
| PBR | UBS | — | $22 → $23 | Target raised to $23 from $22 (+10.8% to spot) | — |
| AZO | Raymond James | — | $4000 → $3700 | Target cut to $3700 from $4000 (+27.8% to spot) | — |
| CFG | Truist | — | $80 → $77 | Target cut to $77 from $80 (+17.6% to spot) | — |
| KMX | Morgan Stanley | — | $44 → $47 | Target raised to $47 from $44 (-17.3% to spot) | — |
| RTX | Bernstein | — | $232 → $223 | Target cut to $223 from $232 (+16.8% to spot) | — |
| HII | Bernstein | — | $341 → $327 | Target cut to $327 from $341 (+20.7% to spot) | — |
| MGY | Siebert Williams | — | $32 | Target set to $32 (+33.2% to spot) | — |
| FSLY | BofA Securities | — | $22 | Target set to $22 (-15.6% to spot) | AEI |
| RXO | Susquehanna | — | $19 | Target set to $19 (-4% to spot) | — |
| HUBS | FBN Securities | — | $230 | Target set to $230 (+5.6% to spot) | AW40 |
| BDC | Needham | — | $140 | Target set to $140 (+23.9% to spot) | — |
| ENHA | Cantor Fitzgerald | — | $4 | Target set to $4 (+168.5% to spot) | — |
| AMRX | Oppenheimer | — | $27 | Target set to $27 (+38.5% to spot) | — |
| TEVA | Oppenheimer | — | $50 | Target set to $50 (+26.5% to spot) | — |
| COLL | Oppenheimer | — | $50 | Target set to $50 (+119.5% to spot) | — |
| PCRX | Oppenheimer | — | $32 | Target set to $32 (+29.6% to spot) | — |
| CRMD | Oppenheimer | — | $15 | Target set to $15 (+92.8% to spot) | — |
| ANIP | Oppenheimer | — | $85 | Target set to $85 (+9.1% to spot) | — |
| VNDA | Oppenheimer | — | $10 | Target set to $10 (+91.9% to spot) | — |
| TTC | Oppenheimer | — | $120 | Target set to $120 (+27% to spot) | — |
| AMGN | Jefferies | — | $410 | Target set to $410 (-0.1% to spot) | HALO |
| VRTX | Jefferies | — | $640 | Target set to $640 (+24.3% to spot) | HALO |
| NKE | Barclays | — | $52 → $48 | Target cut to $48 from $52 (+33% to spot) | — |
| CNI | BofA Securities | — | $143 | Target set to $143 (+19.6% to spot) | — |
| ACN | BMO Capital | — | $200 | Target set to $200 (+8.9% to spot) | — |
| CMPX | Citizens After FDA Dialogue | — | $4 | Target set to $4 (+222.6% to spot) | — |
| FBRT | Market Outperform by Citizens | — | $10 | Target set to $10 (+29% to spot) | — |
| LKFT | RBC Capital | — | $45 | Target set to $45 (+49.1% to spot) | — |
| AVEX | Jefferies | — | $26 | Target set to $26 (+63.5% to spot) | — |
| AZO | Barclays | — | $3637 → $3400 | Target cut to $3400 from $3637 (+17.5% to spot) | — |
| BBNX | Wells Fargo | — | $28 | Target set to $28 (+22.8% to spot) | — |
| PLSE | BTIG | — | $70 | Target set to $70 (+32.9% to spot) | — |
| ORIC | BTIG | — | $26 | Target set to $26 (+92.6% to spot) | — |
| VTRS | Oppenheimer | — | $25 | Target set to $25 (+45.5% to spot) | — |
| APH | Bernstein | — | $99 | Target set to $99 (+19.5% to spot) | Rubin |
| TEL | Bernstein | — | $243 | Target set to $243 (+13.8% to spot) | — |